Gilead Sciences Inc., maker of the world's best-selling AIDS treatment, is offering to help generic-drug makers in India produce the medicine, a move intended to get the life-saving pill to millions more people in the world's poorest countries. Since 2004, Gilead has twice slashed its price for Truvada...Still, only 45,000 to 50,000 of the 6.5 million people in poor countries who need AIDS drugs to stay alive are receiving any of Gilead's medicines. To get the drug to more patients, Gilead is handing over its manufacturing secrets to generic companies who may be able sell the drugs for even less... ``It's a huge change,'' said Helene Gayle, former director of the HIV program at the Bill & Melinda Gates Foundation... ``We just haven't seen this kind of willingness to cooperate before.''...Bristol-Myers Squibb Co. and...Roche...say they are pursuing similar deals... [also refers to Emcure, Aspen Pharmacare, Matrix Laboratories]